Solutions

Providing solutions that enable exponential impact.

Thank you!

You will receive an email with a link to the webinar

Solutions

Providing solutions that enable exponential impact.

Learn more
ws_icon_webinar_wht.png

Share the Science presents: 
Linheng Li, PhD

Webcast now available

Uncover new strategies to manage hematopoietic diseases through HSC self-renewal

Discover how hematopoietic stem cells (HSCs) are regulated, and the ways this understanding can facilitate new strategies to manage hematopoietic diseases. Linheng Li, Ph.D. will discuss his work in RNA modification to promote self-renewal of HSCs, resulting in HSC expansion. Dr. Li examines the key concepts around this research, including:

  • N6-methyladenosine (m6A), the most prevalent RNA modification in eukaryote, shows versatile functions in various physiological processes.
  • The critical role of m6A mRNA methylation in the determination of HSC fate.
  • Suppression of a m6A reader, Ythdf2, has been reported to promote HSCs self-renewal and resulted in expansion

These insights may lead to breakthroughs in the treatment of certain leukemias, lymphomas, and myelomas. Watch now to learn more about this important research.


About Share the Science

Share the Science is a free webinar series designed to bring you powerful presentations by the top experts in cellular therapy. Generously supported by WellSky and Save the Cord Foundation, Share the Science webinars connect you to the world's most innovative and influential scientists, clinical researchers, and experts as they highlight the latest breakthroughs and most promising developments in cellular therapy.

Learn more about Save the Cord Foundation.
Watch now
Recorded June 18, 2020

Revenue Cycle Management

Recorded Oct 23, 2018

WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.

What Types of Emails Do You Want to Receive?

For Which Specialties? Select All That Apply.

By clicking the button above, you are agreeing to our Privacy Policy.
Alvaro Moreira, MD
Presenter: Linheng Li, Ph.D.
Investigator, Stowers Institute for Medical Research, Affiliate Professor at the University of Kansas Medical Center, and Co-Leader of Cancer Biology at the University of Kansas Cancer Center

Linheng Li is best known for using combined genomics and genetics to study stem cells and their associated niches in hematopoietic and intestinal tissues. His recent research has extended into translational medicine by showing that 1) Wnt/β-catenin dependent anti-cancer therapy resistance can be partially overcome via suppressing immune-checkpoint genes in leukemia stem cells, which was verified in human patients in a small scale clinical trial (Nature Cell Biology, 2020); and that 2) expansion of human umbilical cord blood stem cells can take place via targeting the M6A RNA modification pathway.

Presenter

Presenter: Jill Dyer, BSN, RN, HCS-D, HCS-O

People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.

Presenter

Presenter: Jill Dyer, BSN, RN, HCS-D, HCS-O

People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.

Presenter

Presenter: Jill Dyer, BSN, RN, HCS-D, HCS-O

People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.

Hospital
Products & Services

Hospital

Learn More
Practice & Facilities
Products & Services

Practices & Facilities

Learn More
Home Care
Products & Services

Home Care

Learn More

You might also like these resources...

Join us for this free, 5-part training course with over 7 hours of instruction from a renowned faculty.
Download this handy guide to help home health clinicians comply with patient rights standards included in the CoPs. By clinical expert Jill Dyer.
Download this guide to help home health clinicians complete compliant comprehensive assessments required in the CoPs. By clinical expert Jill Dyer.
Description text for this resources goes here. Some info about what to expect with this resource.
Description text for this resources goes here. Some info about what to expect with this resource.

About WellSky

WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.

About Us

About WellSky

People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.

People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.